301 related articles for article (PubMed ID: 18420145)
1. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl-(20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3.
Antony P; Sigüeiro R; Huet T; Sato Y; Ramalanjaona N; Rodrigues LC; Mouriño A; Moras D; Rochel N
J Med Chem; 2010 Feb; 53(3):1159-71. PubMed ID: 20070104
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, evaluation, and structure of vitamin D analogues with furan side chains.
Fraga R; Zacconi F; Sussman F; Ordóñez-Morán P; Muñoz A; Huet T; Molnár F; Moras D; Rochel N; Maestro M; Mouriño A
Chemistry; 2012 Jan; 18(2):603-12. PubMed ID: 22162241
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
6. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
7. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
8. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
[TBL] [Abstract][Full Text] [Related]
9. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
[TBL] [Abstract][Full Text] [Related]
10. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor.
Yamada S; Shimizu M; Yamamoto K
Med Res Rev; 2003 Jan; 23(1):89-115. PubMed ID: 12424754
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a vitamin D3 analog, ZK203278, showing dissociated profile.
Rochel N; Moras D
Anticancer Res; 2012 Jan; 32(1):335-9. PubMed ID: 22213324
[TBL] [Abstract][Full Text] [Related]
13. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
González-Avión XC; Mouriño A; Rochel N; Moras D
J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
[TBL] [Abstract][Full Text] [Related]
14. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
[TBL] [Abstract][Full Text] [Related]
15. Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties.
Olivera CJ; Bula CM; Bishop JE; Adorini L; Manchand P; Uskokovic MR; Norman AW
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):99-106. PubMed ID: 15225754
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
[TBL] [Abstract][Full Text] [Related]
17. Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential.
Gocek E; Kiełbiński M; Wyłób P; Kutner A; Marcinkowska E
Steroids; 2008 Dec; 73(14):1359-66. PubMed ID: 18644400
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3).
Norman AW; Adams D; Collins ED; Okamura WH; Fletterick RJ
J Cell Biochem; 1999 Sep; 74(3):323-33. PubMed ID: 10412035
[TBL] [Abstract][Full Text] [Related]
19. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor ligands for osteoporosis.
Cheskis BJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]